Chu, Kai On
5243  results:
Search for persons X
?
1

Nasal Staphylococcus aureus Carriage and Antimicrobial Resi..:

Hu, Wenjing ; Wang, Yang ; Zhou, Lu...
Infectious Diseases and Therapy.  13 (2024)  6 - p. 1215-1233 , 2024
 
?
 
?
4

Safety and immunogenicity of an Escherichia coli-produced 9..:

Chu, Kai ; Bi, Zhao-Feng ; Huang, Wei-Jin...
The Lancet Regional Health - Western Pacific.  34 (2023)  - p. 100731 , 2023
 
?
8

Head-to-head immunogenicity comparison of an Escherichia co..:

Zhu, Feng-Cai ; Zhong, Guo-Hua ; Huang, Wei-Jin...
The Lancet Infectious Diseases.  23 (2023)  11 - p. 1313-1322 , 2023
 
?
9

A randomized, open-label, phase 3 study evaluating safety a..:

Chu, Kai ; Hu, Yuemei ; Pan, Hongxing...
Human Vaccines & Immunotherapeutics.  19 (2023)  2 - p. , 2023
 
?
13

Efficacy, safety, and immunogenicity of an Escherichia coli..:

Zhao, Fang-Hui ; Wu, Ting ; Hu, Yue-Mei...
The Lancet Infectious Diseases.  22 (2022)  12 - p. 1756-1768 , 2022
 
?
15

Lot-to-lot consistency, immunogenicity, and safety of an in..:

Zhu, Dandan ; Hu, Yuansheng ; Jiang, Zhiwei...
Human Vaccines & Immunotherapeutics.  18 (2022)  6 - p. , 2022
 
1-15